Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Abhijit ChouguleVikas Suri

Abstract

Studies have shown elevated levels of certain coagulation factors as risk factors for venous thromboembolism (VTE). In this study, we investigated the levels of coagulation factor VIII (FVIII), FIX and FXI in north Indian patients with VTE. A total of 123 patients with VTE were screened prospectively for FVIII, FIX and FXI levels and the conventional risk factors - deficiencies of protein C, S and antithrombin, positivity for antiphospholipid antibodies and the factor V Leiden mutation. Age-matched and sex-matched controls were included. VTE was secondary to known circumstantial and thrombophilic risk factors in 66 (53.7%) patients. In 46.3% (idiopathic VTE) patients, no cause was identified. The mean FVIII levels in idiopathic (187 IU/dl) and secondary VTE patients (185.4 IU/dl) were significantly higher compared with controls (129.6 IU/dl; P < 0.001). However, there was no statistically significant difference in the levels of FIX and FXI between patients and controls (P = 0.214 and 0.198, respectively). Patients with elevated FVIII levels had increased risk of VTE compared with controls (odds ratio: 9.4, 95% confidence interval: 4.7-18.79). On logistic regression analysis after adjusting for surgery and presence of antiphosph...Continue Reading

References

Apr 21, 1999·Lancet·F R Rosendaal
Mar 9, 2000·The New England Journal of Medicine·J C MeijersF R Rosendaal
Aug 19, 2000·The New England Journal of Medicine·P A KyrleS Eichinger
Sep 1, 2001·British Journal of Haematology·R LensenF R Rosendaal
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·A WeltermannP A Kyrle
Oct 3, 2003·Journal of Thrombosis and Haemostasis : JTH·G LavigneJ-C Gris
Oct 3, 2003·Journal of Thrombosis and Haemostasis : JTH·G GarewalS Varma
Feb 27, 2004·British Journal of Haematology·Legnani CristinaPalareti Gualtiero
Jan 7, 2005·Journal of Thrombosis and Haemostasis : JTH·A LeizoroviczUNKNOWN SMART Study Group
Aug 12, 2005·Current Opinion in Hematology·Haruka Itakura
Apr 29, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Tayana Bezerra Teixeira MelloJoyce M Annichino-Bizzacchi
Jan 26, 2010·British Journal of Haematology·Linda E FlintermanCarine J M Doggen
Feb 5, 2010·British Journal of Haematology·Trevor BaglinUNKNOWN British Committee for Standards in Haematology
Sep 11, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Tayana B T MelloJoyce M Annichinno-Bizzachi
Apr 19, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi OtaMasaaki Ito
Feb 14, 2013·Blood Cells, Molecules & Diseases·Wei ShenChunmei Ying

❮ Previous
Next ❯

Citations

Aug 8, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Sweta RajpalVarun Uppal
Mar 12, 2020·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Narender KumarPankaj Malhotra

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.